Linköping University Hospital is a university hospital in Linköping, Sweden, operated by Östergötland County. Its scientific activities are integrated into the medical faculty of Linköping University. The hospital has all specializations except organ transplantation.

During the past decade, Uni Hospital Linkoeping; Dept. of Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uni Hospital Linkoeping; Dept. of Oncology" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "University Hospital, Linkoeping" with 2 trials sponsored, "Collaborative Group for Adrenocortical Carcinoma Treatment" with 1 trials sponsored, "Göteborg University" with 1 trials sponsored and "Rectal Cancer Trial on Defunctioning Stoma Study Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uni Hospital Linkoeping; Dept. of Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Uni Hospital Linkoeping; Dept. of Oncology" are "Breast Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Bile Duct Cancer" (1 trials) and "Bile Duct Obstruction" (1 trials). Many other conditions were trialed in "Uni Hospital Linkoeping; Dept. of Oncology" in a lesser frequency.

Most popular intervention types in "Uni Hospital Linkoeping; Dept. of Oncology" are "Drug" (9 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Doxorubicin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Uni Hospital Linkoeping; Dept. of Oncology" are 9 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Uni Hospital Linkoeping; Dept. of Oncology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Uni Hospital Linkoeping; Dept. of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uni Hospital Linkoeping; Dept. of Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".